Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program

Raushan T. Kurmasheva, Melissa Sammons, Edward Favours, Jianwrong Wu, Dias Kurmashev, Katherine Cosmopoulos, Heike Keilhack, Christine R. Klaus, Peter J. Houghton, Malcolm A. Smith

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint Dive into the research topics of 'Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program'. Together they form a unique fingerprint.

Medicine & Life Sciences